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Background: Xanthones are a group of oxygen-containing heterocyclic compounds with remarkable
pharmacological effects such as anti-cancer, antioxidant, anti-inflammatory, and antimicrobial activities.
Methods: A xanthones extract (81% α-mangostin and 16% γ-mangostin), was prepared by crystallization of a
toluene extract of G. mangostana fruit rinds and was analyzed by LC-MS. Anti-colon cancer effect was investigated
on HCT 116 human colorectal carcinoma cells including cytotoxicity, apoptosis, anti-tumorigenicity, and effect on
cell signalling pathways. The in vivo anti-colon cancer activity was also investigated on subcutaneous tumors
established in nude mice.
Results: The extract showed potent cytotoxicity (median inhibitory concentration 6.5 ± 1.0 μg/ml), due to induction
of the mitochondrial pathway of apoptosis. Three key steps in tumor metastasis including the cell migration, cell
invasion and clonogenicity, were also inhibited. The extract and α-mangostin up-regulate the MAPK/ERK, c-Myc/
Max, and p53 cell signalling pathways. The xanthones extract, when fed to nude mice, caused significant growth
inhibition of the subcutaneous tumor of HCT 116 colorectal carcinoma cells.
Conclusions: Our data suggest new mechanisms of action of α-mangostin and the G. mangostana xanthones, and
suggest the xanthones extract of as a potential anti-colon cancer candidate.Background
Garcinia mangostana L. or mangosteen is a tropical tree
from the family Clusiaceae. The tree is cultivated for centur-
ies in Southeast Asia rainforests, and can be found in many
countries worldwide [1]. Pericarps of the fruit have been
used in folk medicine for the treatment of many human ill-
nesses such as skin and wound infections, and inflammatory
diseases [2]. Mangosteen is also used as an ingredient in
several commercial products including nutritional supple-
ments, herbal cosmetics, and pharmaceutical products [1].
Mangosteen fruit rinds contain high concentration of xan-
thones. α-Mangostin (1,3,6-trihydroxy-7-methoxy-2,8-bis
(3-methyl-2-butenyl)-9 H-xanthen-9-one), and γ-mangostin
(1,3,6,7-tetrahydroxy-2,8-bis(3-methylbut-2-enyl)xanthen-9-
one) (Figure 1) are the main xanthones isolated from
G. mangostana [3,4].* Correspondence: abedaisheh@yahoo.com; aminmalikshah@gmail.com
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reproduction in any medium, provided the orThe G. mangostana xanthones are gaining more and
more interest due to their remarkable pharmacological
effects including analgesic [5], antioxidant [6], anti-
inflammatory [7], anti-cancer [8-11] anti-allergy [12], anti-
bacterial [13], anti-tuberculosis [14], antifungal [15],
antiviral [16], cardioprotective [17], neuroprotective [18],
and immunomodulation [19] effects.
Colorectal cancer is the third in incidence after lung
and breast cancers and accounts for almost 10% of total
cases of cancer and almost 8% of total cancer deaths
[20]. According to the World Health Organization
(WHO), more than 70% of all cancer deaths occurred in
countries with low and middle income, and deaths from
cancer worldwide are projected to continue to rise to
over 11 million in 2030 [21]. Hence, there is an increas-
ing demand for cost-effective therapeutics and chemo-
prevention agents for the various types of cancer.
Several studies have shown natural products, particularly
medicinal plants as potential chemoprevention and anti-
cancer candidates.
Anti-cancer properties of G. mangostana extracts or
pure xanthones have been extensively studied in vitro,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Chemical structure of α-mangostin and γ-mangostin,
the main constituents of the G. mangostana xanthones extract.
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be traced. Xanthone extracts from G. mangostana have
been reported with chemoprevention effects against
the chemically induced colon cancer [8], suppression of
tumor growth and metastasis in a mouse model of
mammary cancer [9], and a recent report showed the
inhibition of prostate cancer growth by α-mangostin, the
main constituent of the G. mangostana xanthones [22].
This study aims to investigate the in vitro anti-colon
cancer properties of a G. mangostana xanthones extract
(81% α-mangostin and 16% γ-mangostin) on HCT 116
human colorectal carcinoma. The in vitro anti-cancer
effects include cytotoxicity, apoptosis, cell migration, cell
invasion, and clonogenicity. The mechanism of action of
the xanthones extract and α-mangostin on the transcrip-
tion factor level of 10 signalling pathways involved in
colon carcinogenesis was also investigated. The study
also aims to investigate the in vivo anti-colon cancer
effect on a pre-established subcutaneous tumor of HCT
116 cells in NCR nude mice.
Methods
Cell lines and reagents
Human colorectal carcinoma cell line HCT 116;
Catalogue number (CCL-247) and CCD-18Co normal
colonic fibroblast; Catalogue number (CRL-1459) were
purchased from the American Type Culture Collection
(ATCC; Manassas, Virginia). RPMI 1640, Opti-MEMW
and DMEM cell culture media, heat inactivated fetal
bovine serum (HI-FBS), and phosphate buffered saline
(PBS) without calcium and magnesium were purchased
from Bio-Diagnostics (Petaling Jaya, Selangor, Malaysia).
Cignal finder™ 10-pathway reporter-array system, and
matrigel matrix (10 mg/ml) were purchased from
SABiosciences (Frederick, Maryland). WizardW SV gen-
omic DNA purification system, caspases-3/7, -8 and −9
reagents, trans fast liposome, and dual luciferase reporter
system were purchased from Promega (Petaling Jaya,
Selangor, Malaysia). Cisplatin, Hoechst 33258, Rhodamine
123, agarose, ethidium bromide, penicillin/streptomycin
(PS) solution, dimethylsulfoxide (DMSO), phenazine
methosulfate (PMS), and 2,3-Bis(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt(XTT) were purchased from Sigma-Aldrich (Kuala Lum-
pur, Malaysia). The solvents were of analytical or HPLC
grade and were obtained from Avantor Performance
Materials (Petaling Jaya, Selangor, Malaysia).
Plant material and extraction
Ripened G. mangostana fruit was collected from a local
fruit farm at Island of Penang, Malaysia. A voucher spe-
cimen (11155) was deposited at the Herbarium of School
of Biological Sciences, USM. The fruit rind was chopped
and dried at 45–50°C for 24 h. Toluene extract was pre-
pared by maceration method at 1:5 plant: solvent ratio
(wt/v), at 60°C for 48 h. The extract was filtered, concen-
trated at 60°C by rotavapor to about 150 ml, and crystal-
lized at 2–8°C for 24 h. A yellow solid was formed,
which was collected and dried at 50°C.
Animals
Athymic NCR nu/nu nude mice were obtained from
Taconic Farms Inc. (Hudson, New York). Mice were
housed in specific pathogen free (SPF) cages supplied
with high efficiency particulate air (HEPA) filters. Free
access to autoclaved food and water was provided and the
autoclaved bedding was changed twice weekly. The proce-
dures were approved by the USM Animal Ethics Commit-
tee with a reference number PPSG/07(A)/044/(2010) (59).
Liquid chromatography-mass spectrometry (LC-MS)
The xanthones extract was analyzed by a Dionex-
UltimateW 3000 Rapid Separation LC system (Dionex,
Sunnyvale, California), connected with a Micro TOF-Q
mass spectrometer (Bruker, Madison, Wisconsin). Chro-
matographic separation was performed using Nucleosil
C18 column (5 μm, 4.6 × 250 mm) (Macherey-Nagel,
Bethlehem, Pennsylvania), at 30°C, the mobile phase was
consisting of 95% acetonitrile and 5% of 0.1% formic
acid in water. The flow rate was set at 0.5 ml/min for
15 min, and spectral data were collected at 244 nm.
Mass analysis was performed in the range 50–1000 m/z,
under negative ion mode, and the nebulizer was set at
3.0 bar and heated to 150°C. The capillary voltage was
set at 3000 V using a nitrogen dry gas at 8.0 L/min. The
end plate offset was maintained at −500 V.
Cell culture
HCT 116 cells were maintained in RPMI 1640 medium
supplemented with 10% HI-FBS and 1% PS, and the
CCD-18Co cells were maintained in DMEM medium sup-
plemented with 10% HI-FBS and 1% PS. Cells were cul-
tured in a 5% CO2 in a humidified atmosphere at 37°C.
Cell viability
Cell viability was determined by the XTT test as
described previously [23]. Briefly, cells were treated for
Aisha et al. BMC Complementary and Alternative Medicine 2012, 12:104 Page 3 of 10
http://www.biomedcentral.com/1472-6882/12/10448 h, the culture medium was removed and replaced
with a fresh one containing XTT and PMS at 100 μg/ml
and 1 μg/ml, respectively. After incubation for 4 h, the
optical density was measured at a wavelength of 450 nm,
using a microplate reader (Thermo Fisher Scientific,
Ratastie, Vantaa, Finland). The results are presented as a
percentage inhibition to the negative control (0.5%







The median inhibitory concentrations (IC50s) were cal-
culated from the dose response curves (n = 3).
Caspases-3/7, -8 and −9
HCT 116 cells were treated in a white 96-well plate for
90 min. Subsequently, the caspases activity was mea-
sured by caspase Glo 3/7, Glo 8 and Glo 9 as described
previously [24]. Luminescence was measured by a
microplate reader (Hidex, Mustionkatu, Turku, Finland),
and the results are presented as a mean of relative light
units (RLU) ± SD (n = 4).
Mitochondrial membrane potential and chromatin
condensation
Rhodamine 123 and Hoechst 33258 were used as probes
to study the effect on mitochondrial membrane potential
and chromatin condensation [25,26]. Briefly, HCT 116
cells were treated with α-mangostin or the xanthones
extract at different concentrations for 2 h. Subsequently,
cells were fixed in 4% paraformaldehyde for 20 min, sim-
ultaneously stained with rhodamine 123 at 1 μg/ml and
Hoechst 33258 at 10 μg/ml for 20 min, washed exten-
sively with PBS, and examined immediately using IX71
inverted fluorescent microscopy (Olympus, Shinjuku,
Tokyo, Japan). Cell morphology was evaluated by study-
ing 5 randomly selected microscopic fields and the
apoptotic index was calculated.
DNA fragmentation
HCT 116 (2× 106) cells were treated for 48 h. Subse-
quently, the floating and attached cells were collected by
centrifugation at 3000 rpm for 10 min, the total genomic
DNA was extracted using WizardW SV genomic DNA
purification system, and analyzed by electrophoresis on
1.2% agarose gel stained with 0.5 μg/ml ethidium bromide.
Anti-tumorigenicity
Anti-tumorigenicity studies including clonogenicity, cell
migration, and cell invasion were investigated on HCT
116 cells. Effect on the clonogenicity was evaluated bythe colony formation assay as previously described [27].
Five hundred cells were seeded in 6-well plate in 2.5 ml
of RPMI 1640 medium, and were incubated to allow
attachment. Subsequent to 48 h treatment, the drug was
removed and cells were incubated in a fresh medium for
12 days. Colonies were fixed in 4% paraformaldehyde,
stained with 0.5% crystal violet, and counted under a
stereomicroscope. The plating efficiency (PE) of
untreated cells and the survival fraction (SF) of treated
cells were then determined (n = 3).
The effect on cell migration was studied by the wound
healing assay as described previously [28]. Cell’s mono-
layer was scratched using a 200-μl micropipette tip, the
detached cells were washed off, and the cells were treated
in a medium containing 2% serum. The wounds were
then photographed at zero time and incubated for 24 h.
The distance of cell-free wounds was then measured using
a Leica QWin image analysis software (Leica Microsys-
tems Inc., Buffalo Grove, Illinois), and the percentage of
wound closure was calculated relative to zero time.
Effect on cell invasion was studied by a modification
of the Boyden chamber assay using matrigel matrix [29].
Basically, 50 μl of matrigel (5 mg/ml) was loaded into
96-well plate and allowed to solidify for 45 min. Treated
cells (5 × 103 in 150 μl RPMI medium) was added to
each well and incubated for 48 h. Subsequently, cells
were washed with PBS and the number of the invading
cells was determined under inverted light microscopy.
The results are presented as a percentage inhibition to
untreated cells (n = 3).
Effect on cell signalling pathways
The assay was performed in 96-well plate format accord-
ing to the manufacturer’s instructions. Briefly, HCT 116
cells were transfected by reverse transfection with DNA
constructs of 10 signalling pathways, a positive control,
and a negative control. After overnight incubation, cells
were treated for 6 h in complete RPMI medium. Subse-
quently, the activity of Firefly and Renilla luciferases was
measured using dual-luciferase assay. The results are
displayed as relative luciferase units, generated by divid-
ing the Firefly/Renilla ratio of transcription factor-
responsive reporter transfections by the Firefly/Renilla
ratio of negative control transfections (n = 3). The fold
change in the transcription factor activity was then
calculated by dividing the results of the treated cells by
that of untreated cells.
In Vivo anti-tumor activity
Twenty four nude mice aged 6–8 weeks with average
weight of 25 g were injected subcutaneously in right
flank with 5 × 106 cells in 150 μl RPMI. After 7–10 days,
animals with uniform tumor size were divided into 3
groups of 6 animals. Tumor size and body weight were
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intervals for 20 days. Animals were treated by mixing
the extract with the animal food at 0.25% and 0.5%
extract: food ratio (wt/wt). Tumor dimensions were
measured by a calibre in 2 angles, length and width [30].
Tumor size was then calculated as described previously
[30-32], by applying the formula (((W+L)/2) ^ 3) × 2,
where W is the width and L is the length. Tumor size in
tumors with more than a lobe was calculated by summa-
tion of the size of the individual lobes [30]. Cross sec-
tions of the tumors were then prepared, stained with
Eosin/Hematoxylin, and were studied for presence of
necrotic cells and for the number of intratumor blood
vessels. Blood vessels were counted at 20× magnification
in 25 microscopic fields per tumor, and the results are
presented as average number of blood vessels per
tumor ± SD.
Statistical analysis
The results are presented as mean ± SD. The differences
between groups were compared by One-way ANOVA,
and were considered significant at P< 0.05. Data analysis
was carried out using SSPS 16.0 software.
Results
Phytochemical analysis
The extract was obtained at 5% yield (wt/wt) relative
to the dry plant material. LC-MS analysis indicates
the presence of 5 compounds; α-mangostin, was 81%,
γ-mangostin was 16%, and the other 3 compounds were
3%, the percentage of the compounds was calculated
based on the peak area (Table 1).
Cytotoxicity
The xanthones extract, α-mangostin, and γ-mangostin
caused dose dependent killing of the colon cancer
cells (Figure 2a), showing IC50s of 6.5 ± 1.0 μg/ml,
5.1 ± 0.2 μg/ml, and 7.2 ± 0.4 μg/ml, respectively. CCD-
18Co normal cells, unlike HCT 116 cells, were 2 folds less
sensitive showing IC50 of 11.1± 0.4 μg/ml (α-mangostin),
and 13.0± 0.6 μg/ml (xanthones extract). Cisplatin, as a
positive control, also showed dose dependent cytotoxicity
on colon cancer cells giving IC50 of 6.1 ± 0.2 μg/ml.
Effect on caspases-3/7,-8 and −9
α-Mangostin and the xanthones extract at 10 and 20 μg/
ml, showed a rapid enhancement of the caspases-3/7
activity after a treatment for 90 min (Figure 2b). At a
concentration of 5 μg/ml, a slight but not significant
increase in the activity was achieved (P> 0.05). The
treatment compounds also caused significant enhance-
ment of the caspase-9 activity in HCT 116 cells, but not
caspase-8 activity (Figure 2c). The increase in caspase-9
activity was almost 8-folds more than that of caspase-8.Effect on DNA fragmentation
Analysis of the total genomic DNA by agarose gel elec-
trophoresis revealed apparent DNA fragmentation in
HCT 116 cells (Figure 2d). The results indicate that the
effector caspases executed the apoptotic signal stimu-
lated by the treatment compounds.
Effect on mitochondrial membrane potential
of HCT 116 cells
The rhodamine staining showed a distinct morphology
of the apoptotic cells, which were stained more brightly
than the non-apoptotic cells (Figure 3a). The result indi-
cates lower concentration of rhodamine 123 due to loss
of mitochondrial membrane potential. The apoptotic
index of α-mangostin-treated cells at 20 μg/ml was
(55 ± 9)%, and that of the xanthones extract was
(13.2 ± 2.4)%, (38 ± 4.5)%, (47 ± 4.5)%, and (68 ± 9)% at
7.5, 10, 15 and 20 μg/ml, respectively. Significant induc-
tion of apoptosis, compared to untreated cells
(5.1 ± 2.3)%, was obtained at the last 3 concentrations
(P = 0.0), whereas no significant effect was observed at a
concentration of 7.5 μg/ml (P = 0.2).
Effect on chromatin condensation and nuclear
fragmentation
α-Mangostin at 20 μg/ml, and the xanthones extract
caused significant and dose dependent induction of
chromatin condensation and nuclear fragmentation in
HCT 116 cells after 2 h treatment. Staining with the
DNA probe Hoechst 33258 produced a distinct nuclear
morphology of the apoptotic cells, which were stained
more brightly, with or without nuclear fragmentation,
whereas the non-apoptotic cells showed uniformly
stained nuclei at lower intensely (Figure 3b). The apop-
totic index of α-mangostin-treated cells was (47 ± 5.5)%,
and that of the extract was (4.4 ± 3)%, (37 ± 7)%,
(39 ± 10)%, and (52 ± 9)% at 7.5, 10, 15 and 20 μg/ml, re-
spectively. Compared with the vehicle alone (3.3 ± 3)%,
significant induction of apoptosis was obtained at 10, 15
and 20 μg/ml (P = 0.0), whereas the treatment at 7.5 μg/
ml did not show any apoptotic effect, (P = 0.99).
Anti-tumorigenicity
The compounds inhibited the clonogenicity of HCT 116
cells (Figure 4a). The PE was (54± 2)%, and the SF in cells
treated with the xanthones extract was 0% at all con-
centrations. The SF in α-mangostin treated cells was 0%
at 20, 15, 10 and 7.5 μg/ml, and (7.8± 0.3)% at 5 μg/ml.
Cell migration was also inhibited in both treatments
(Figure 4b). The percentage of wound closure in the un-
treated cells was (65 ± 4.3)%. α-Mangostin, at 5 μg/ml,
reduced the percentage of wound closure to (41 ± 2.7)%,
(P = 0.0). Likewise, the xanthones extract, at 3 and
5 μg/ml, reduced the wound closure percentage to
Table 1 Mass spectrometry of the G. mangostana xanthones extract
Peak No Retention
time (min)





1 7.4 ± 0.006 1.4 ± 0.1 413.1408 C23H26O7 Garcinone C
414.1443
415.1397
2 7.8 ± 0.001 15.6 ± 1.6 395.1308 C23H24O6 γ-mangostin
396.1338
397.1360
3 8.8 ± 0.013 1.2 ± 0.1 379.1370 C23H24O5 8-deoxygartanin
380.1381
381.1440
4 9.2 ± 0.001 80.8 ± 1.6 409.1452 C24H26O6 α-mangostin
410.1489
411.1526
5 13.5 ± 0.005 0.9 ± 0.03 423.1604 C25H28O6 β-mangostin
424.1631
425.1667
The mass was recorded in the negative ion mode (n = 4).
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of matrigel was also inhibited by α-mangostin at 6 μg/ml
(78 ± 6)%, and by the xanthones extract at 6 μg/ml
(78 ± 8)% and 4.5 μg/ml (57 ± 8)%. Besides reducing theFigure 2 Cytotoxic and apoptotic effects of α-mangostin and the xan
xanthones extract on HCT 116 and CCD-18Co cells in the concentration ran
−9 (c). Effect on DNA fragmentation (d): the negative control was 0.5% DM
xanthones extract was applied at 10, 20, 30 and 40 μg/ml. (*) indicates P<number of matrigel-invading cells, the treatment com-
pounds also caused morphological changes in the treated
cells characterized by cytoplasmic shrinkage and contrac-
tion of cellular polypodia (Figure 4c).thones extract on HCT 116 cells. Dose response curves of the
ge 2.5 – 30 μg/ml (a). Effect on caspases-3/7 (b), and caspases-8 and
SO, the positive control was α-mangostin at 20 μg/ml, and the
0.05.
Figure 3 Effect the xanthones extracts on mitochondrial membrane potential and chromatin condensation. The mitochondrial
membrane potential (a): negative control (1), α-mangostin at 20 μg/ml (2) and the xanthones extract at 20 μg/ml (3). Chromatin condensation
(b): negative control (1), α-mangostin at 20 μg/ml (2) and the xanthones extract at 20 μg/ml (3).
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The transfected HCT 116 cells were treated at 2 con-
centrations 7.5 and 10 μg/ml for 6 h, and the results in
the treated cells were compared to those treated with
the vehicle alone (0.5% DMSO). The transcription factorFigure 4 Anti-tumorigenicity effect of the xanthones extract on HCT 1
5 μg/ml (2) and the xanthones extract at 5 μg/ml (3). Cell migration (b): wo
negative control (2), α-mangostin at 5 μg/ml (3) and the xanthones extract
6 μg/ml (2) xanthones extract at 6 μg/ml (3) and at 4.5 μg/ml (4).activity of the 10 pathways is reduced by treating the
cells with 10 μg/ml of the xanthones extract and α-
mangostin. However, the treated cells showed apoptotic
morphology, which indicates the downregulation of sig-
nalling pathways occurred as a consequence of apoptosis.16 cells. Clonogenicity (a): negative control (1), α-mangostin at
unds photographed at zero time (1), and the treated cells after 24 h;
at 5 μg/ml (4). Matrigel invasion (c): untreated cells (1), α-mangostin at
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in the treated cells, but resulted in differential effects on
the signalling pathways. The fold changes in the tran-
scription factor activity in cells treated at 7.5 μg/ml is
displayed in Figure 5. The transcription factor activity
of the MAPK/ERK pathway was increased by 71% in
α-mangostin-treated cells and 97% in the xanthones
extract-treated cells. Activity of the Myc/Max signalling
pathway was also increased by 48% in α-mangostin and
60% in the xanthones extract-treated cells. In addition,
the activity of the p53 signalling pathway was increased
by 30% in α-mangostin-treated cells and 50% in the
xanthones extract-treated cells. On the contrary, the
activity of the NFKB pathway was inhibited by 30% in
α-mangostin treatment and by 13% in the extract-treated
cells. On other hand, the treatment compounds did not
cause any significant changes in the Wnt, Notch, TGFB,
cell cycle, hypoxia and MAPK/JNK signalling pathways.
In Vivo anti-colon cancer effect
The in vivo anti-colon cancer effect of the xanthones
extract was investigated on the HCT 116 subcutaneous
tumor model established in NCR nu/nu nude mice. The
results are presented as average tumor size ± SD (n = 6).
The treatment with the α-mangostin extract caused
apparent necrosis of the pre-established tumors in 2 ani-
mals (Figure 6a), and caused significant reduction in the
tumor size compared to untreated group. Data analysis
was performed by considering the tumor size on 5-days
intervals and showed that significant reduction in tumor
size was achieved after 15 days (0.5% wt/wt), and 20 days
(0.25% wt/wt) of treatment, P< 0.05, (Figure 6b). Ana-
lysis of the tumor cross sections revealed apparent dif-
ferences in the extent of necrotic regions between the
treated versus untreated tumors (Figure 6c). The nec-
rotic/apoptotic cells in treated tumors predominate over
the viable tumor cells which appear as islands in the
middle of necrotic cells. On the contrary, untreatedFigure 5 Effect of the xanthones extract and α-mangostin (7.5 μg/ml)
The fold changes in the transcription factor activity were calculated by divid
cells. The fold change of (1) indicates no activity.tumors were more compact with more abundance of
viable tumor cells.
The average number of intratumor blood vessels was
3.9 ± 0.6/microscopic field (0.5% wt/wt) and 4 ± 0.3/
microscopic field (0.25% wt/wt), was significantly lower
than that in the control group (7.8 ± 1.2), P = 0.0.
Additionally, effect on the animal body weight was
also investigated and the results are presented as average
percentage of weight gain or loss. The data showed a
slight, but not statistically significant weight loss in the
treated groups −4.4 ± 10% (0.5% wt/wt) and −1.5 ± 2.4%
(0.25% wt/wt), compared to 5.3 ± 6% (control group),
P = 0.1 and 0.4, respectively.
Discussion
The xanthones extract of G. mangostana fruit rinds con-
tains mainly α-mangostin and γ-mangostin. The HCT
116 cell line was selected as a model of human colorec-
tal carcinoma [33], and CCD-18Co human normal fibro-
blast was selected as a control cell line. The cytotoxicity
of the xanthones extract, α-mangostin and γ-mangostin
was comparable to that of cisplatin, and the xanthones
extract was almost 2 times more cytotoxic on the colon
cancer cells than on the normal cells, which indicates
higher selectivity towards the colon cancer cells.
Apoptosis studies revealed enhancement of the execu-
tioner caspases-3/7, activation of the initiator caspase-9,
induction of DNA fragmentation and chromatin con-
densation, and loss of mitochondrial membrane poten-
tial. These results indicate the role of the mitochondrial
pathway of apoptosis in mediating cytotoxicity of the
compounds. Our results are consistent with the previous
results of other researchers [10,34], and provide further
evidence on apoptotic effects of G. mangostana, and
indicate the xanthones of this fruit as potential anti-
cancer candidates.
Sub-cytotoxic concentrations of α-mangostin and the
xanthones extract inhibited 3 key steps in tumoron the transcription factor activity of 10 cell signalling pathways.
ing the relative light units in the treated cells by that of the untreated
Figure 6 The subcutaneous tumors in NCR nude mice (a): Untreated group (1), and the treated group at 0.5% wt/wt of the xanthones
extract (2). Analysis of tumor size (b): analysis of tumor size versus time (days) after treatment with the xanthones extract at 2 doses 0.5% and
0.25% wt/wt compared to the control group (untreated). (*) refers to significant difference between both treated groups (P< 0.05) and the
control, and (#) refers to significant difference between the 0.5% group and the control in each corresponding interval. Cross sections of tumor
tissues (c): untreated animals (1), 0.5% treated group (2) and the 0.25% treated group (3). The tissues were stained with Hematoxylin-eosin and
the pictures were captured at 5× magnification. (N) refers to necrotic cells and (V) refers to viable tumor cells.
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clonogenicity. These results, in combination the results
of other researchers [9,35], indicate the potential anti-
metastatic effect of the G. mangostana xanthones.
In order to gain deeper insights into the mechanism of
action, a cell-based reporter assay was used to study the
effect of α-mangostin and the xanthones extract on the
transcription factor activity of the Notch, Wnt/β-Catenin,TGFβ, p53, HIF, Myc, E2F, NFKB, MAPK/ERK (SRE),
and MAPK/JNK (AP-1) signalling pathways. The com-
pounds enhanced the transcription factor activity of the
MAPK/ERK, Myc/Max, and p53/DNA damage signalling
pathways. Previous research showed that the activated
ERK pathway is associated with increased stability and
activity of p53, and increased stability of c-Myc that
in turn increases the proapoptotic effects of p53 tumor
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activation of the ERK pathway is implicated in inducing
apoptosis, as a consequence of DNA damage caused by
cisplatin [38], etoposide [39], doxorubicin, and ionizing
and Ultraviolet irradiation [40]. Therefore, upregulation of
the ERK pathway may provide a therapeutic target for dif-
ferent types of cancer [41-43], however further investi-
gation is required to study the effect of the activated
ERK pathway on the expression of the proapoptotic pro-
teins such as p21 and Bax. α-Mangostin also caused
inhibition of the NFKB pathway. The downregulation of
this pathway is associated with increased sensitivity of
chemoresistant cells [44], and hence α-mangostin may
sensitize the colon cancer cells to the apoptotic effect
of chemotherapeutics.
Different mechanisms of action of mangostins have
been reported including upregulation of the ERK ½ in
DLD-1 colon cancer cells [8], inhibition of TCF/β-catenin
transcriptional activity in colon cancer cells [11], and inhi-
bition of the MAPK/ERK, MAPK/JNK and Akt signalling
pathways in human chondrosarcoma cells [45]. These
findings indicate that mangostins may work by different
mechanisms in different tumor cells. Drug concentration
and duration of treatment have significant effects on via-
bility of cells, and hence these may have substantial effect
on the activity of signalling pathways.
The In vivo anti-colon cancer study revealed significant
inhibition of the tumor growth. The Anti-tumor effect of
the extract may be explained due to direct cytotoxicity
on the tumor cells as evident by the presence of exten-
sive necrosis in the subcutaneous tumors, or due to
reducing the intratumor blood supply as evident by the
significant reduction in the number of intratumor blood
vessels, or due to combination of both mechanisms.
Conclusions
Taken together, our data suggest new mechanisms of
action of α-mangostin and suggest the xanthones extract of
G. mangostana as a potential anti-colon cancer candidate.
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